Antitumor and antiangiogenic effects of Tonantzitlolone B, an uncommon diterpene from Stillingia loranthacea
- PMID: 34854946
- DOI: 10.1007/s00210-021-02185-0
Antitumor and antiangiogenic effects of Tonantzitlolone B, an uncommon diterpene from Stillingia loranthacea
Abstract
Natural products have played a pivotal role for the discovery of anticancer drugs. Tonantzitlolones are flexibilan-type diterpenes rare in nature; therefore, few reports have shown antiviral and cytotoxic activities. This study aimed to investigate the in vivo antitumor action of Tonantzitlolone B (TNZ-B) and its toxicity. Toxicity was evaluated in mice (acute and micronucleus assays). Antitumor activity of TNZ-B (1.5 or 3 mg/kg intraperitoneally - i.p.) was assessed in Ehrlich ascites carcinoma model. Angiogenesis and reactive oxygen species (ROS) and nitric oxide (NO) production were also investigated, in addition to toxicological effects after 7-day treatment. The LD50 (lethal dose 50%) was estimated at around 25 mg/kg (i.p.), and no genotoxicity was recorded. TNZ-B reduced the Ehrlich tumor's volume and total viable cancer cell count (p < 0.001 for both). Additionally, TNZ-B reduced peritumoral microvessel density (p < 0.01), suggesting antiangiogenic action. Moreover, a decrease was observed on ROS (p < 0.05) and nitric oxide (p < 0.001) levels. No significant clinical findings were observed in the analysis of biochemical, hematological, and histological (liver and kidney) parameters. In conclusion, TNZ-B exerts antitumor and antiangiogenic effects by reducing ROS and NO levels and has weak in vivo dose-repeated toxicity. These data contribute to elucidate the antitumor action of TNZ-B and point the way for further studies with this natural compound as an anticancer drug.
Keywords: Angiogenesis; Ehrlich tumor; Tonantzitlolone B; Toxicity.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Abreu LS, Nascimento YM, Costa RS, Guedes MLS, Souza BNRF, Pena LJ, Costa VCO, Scotti MT, Braz-Filho R, Barbosa-Filho JM, Silva MS, Velozo ES, Tavares JF (2019) Tri- and diterpenoids from Stillingia loranthacea as inhibitors of Zika virus replication. J Nat Prod 82(10):2721–2730. https://doi.org/10.1021/acs.jnatprod.9b00251 - DOI - PubMed
-
- Almeida RN, Falcão ACGM, Diniz RST, Quintans-Júnior LJ, Polari RM, Barbosa-Filho JM, Agra MF, Duarte JC, Ferreira CD, Antoniolli AR, Araújo CC (1999) Metodologia para avaliação de plantas com atividade no Sistema Nervoso Central e alguns dados experimentais. Rev Bras Farmacogn 80:72–76
-
- Auletta CS (1995) Acute, subchronic, and chronic toxicology. In: Handbook of toxicology, Derelanko HJ, Hollinger MA (Eds) CRC Press, London, pp. 51–162. https://doi.org/10.1002/food.19960400524
-
- Busch T, Dräger G, Kunst E, Benson H, Sasse F, Siems K, Kirschning A (2016) Synthesis and antiproliferative activity of new tonantzitlolone-derived diterpene derivatives. Org Biomol Chem 14(38):9040–9045. https://doi.org/10.1039/C6OB01697A - DOI - PubMed
-
- Busch T, Schuster H, Kirschning A (2008) Determination of the absolute configuration of the diterpene Tonantzitlolone B. Tetrahedron Lett 49(36):5273–5275. https://doi.org/10.1016/j.tetlet.2008.06.105 - DOI